Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic

Mycobacterium tuberculosis and Mycobacterium avium multiply in cultured human macrophages (MP) within membrane-enclosed vesicles. These vesicles are generally assumed to be acidic. The evidence most frequently cited for this assumption is that pyrazinamide, which requires an acid pH to be effective, is effective and streptomycin, which loses most of its activity at a low pH, is poorly effective against tubercle bacilli. This assumption was tested by using the two weak bases chloroquine and NH4Cl to raise the pH of acidic vesicles in MP experimentally infected with M. tuberculosis or M. avium. An immunocytochemical locator of acidic regions in the MP was used to monitor the association of intracellular bacilli with acidity. MP were infected with M. tuberculosis or M. avium and incubated with various combinations of the drugs and the weak bases. Replication of the bacteria in the MP was measured by culture counts. Intracellular associations of the mycobacteria with acidity were assessed by electron micrographs and by using the weak base 3-(2,4-dinitroanilino)-3'-amino-N-methyl dipropylamine, which was detected with colloidal gold-labeled antibodies. It was confirmed by immunocytochemistry that both chloroquine and NH4Cl raise the pH of acidic vesicles in the infected MP. However, neither caused any pH-related change in the antimycobacterial activities of pyrazinamide or streptomycin or of the pH-independent drug isoniazid. Immunochemical analyses showed acidity to be associated with killed but not living mycobacteria in the MP. These findings suggest that living M. tuberculosis and M. avium are located in human MP in vesicles which are not acidic.

[1]  A. J. Crowle,et al.  Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3 , 1990, Antimicrobial Agents and Chemotherapy.

[2]  L. Reller,et al.  Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system. , 1990, The Journal of infectious diseases.

[3]  V. Nussenzweig,et al.  The exit of Trypanosoma cruzi from the phagosome is inhibited by raising the pH of acidic compartments , 1990, The Journal of experimental medicine.

[4]  A. J. Crowle,et al.  Inhibition by normal human serum of Mycobacterium avium multiplication in cultured human macrophages , 1989, Infection and immunity.

[5]  M. Salfinger,et al.  1,25(OH)2-vitamin D3 synergizes with pyrazinamide to kill tubercle bacilli in cultured human macrophages. , 1989, The American review of respiratory disease.

[6]  M. A. Steele,et al.  The role of pyrazinamide in tuberculosis chemotherapy. , 1988, Chest.

[7]  Nalin Rastogi,et al.  Mechanisms of pathogenicity in mycobacteria. , 1988, Biochimie.

[8]  P. Chang,et al.  Effect of ammonium chloride on subcellular distribution of lysosomal enzymes in human fibroblasts. , 1988, Experimental cell research.

[9]  M. Colston,et al.  The processing and presentation of mycobacterial antigens by human monocytes , 1988, European journal of immunology.

[10]  A. J. Crowle,et al.  Effects of isoniazid and of ceforanide against virulent tubercle bacilli in cultured human macrophages. , 1988, Tubercle.

[11]  A. J. Crowle.  The Tubercle Bacillus­ Human Macrophage Relationship Studied In Vitro , 1988 .

[12]  P. Schlesinger,et al.  Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum. , 1987, The New England journal of medicine.

[13]  M. Iseman,et al.  Pyrazinamide is not active in vitro against Mycobacterium avium complex. , 1986, The American review of respiratory disease.

[14]  E. Goldstein,et al.  Acidification of phagosomes in murine macrophages: blockage by Nocardia asteroides. , 1986, The Journal of infectious diseases.

[15]  A. J. Crowle,et al.  Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages , 1986, Journal of clinical microbiology.

[16]  A. J. Crowle,et al.  Inhibition by pyrazinamide of tubercle bacilli within cultured human macrophages. , 1986, The American review of respiratory disease.

[17]  C. de Chastellier,et al.  Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium , 1986, Infection and immunity.

[18]  I Mellman,et al.  Acidification of the endocytic and exocytic pathways. , 1986, Annual review of biochemistry.

[19]  Richard G. W. Anderson,et al.  Vesicles and cisternae in the trans golgi apparatus of human fibroblasts are acidic compartments , 1985, Cell.

[20]  L. Sibley,et al.  Phagosome acidification blocked by intracellular Toxoplasma gondii , 1985, Nature.

[21]  F. Maxfield,et al.  Legionella pneumophila inhibits acidification of its phagosome in human monocytes , 1984, The Journal of cell biology.

[22]  A. J. Crowle,et al.  Inhibition by streptomycin of tubercle bacilli within cultured human macrophages. , 1984, The American review of respiratory disease.

[23]  M. Brown,et al.  Visualization of acidic organelles in intact cells by electron microscopy. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Lowrie.  The macrophage and mycobacterial infections. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[25]  S. Ohkuma,et al.  Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages , 1981, The Journal of cell biology.

[26]  B Poole,et al.  Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances , 1981, The Journal of cell biology.

[27]  D. Mitchison,et al.  The early bactericidal activity of drugs in patients with pulmonary tuberculosis. , 2015, The American review of respiratory disease.

[28]  P. D'Arcy Hart,et al.  Ammonia inhibits phagosome–lysosome fusion in macrophages , 1980, Nature.

[29]  J. Grosset.  The sterilizing value of rifampicin and pyrazinamide in experimental short-course chemotherapy. , 1978, Bulletin of the International Union against Tuberculosis.

[30]  R. Estabrook,et al.  Microenvironments and metabolic compartmentation , 1978 .

[31]  D. Bainton,et al.  Changes in pH within the phagocytic vacuoles of human neutrophils and monocytes. , 1978, Laboratory investigation; a journal of technical methods and pathology.

[32]  J. Armstrong,et al.  Strain Virulence and the Lysosomal Response in Macrophages Infected with Mycobacterium tuberculosis , 1974, Infection and immunity.

[33]  T. Jones.  Macrophages and intracellular parasitism. , 1974, Journal of the Reticuloendothelial Society.

[34]  J. Armstrong,et al.  Ultrastructural Study of the Behavior of Macrophages Toward Parasitic Mycobacteria , 1972, Infection and immunity.

[35]  T. Ramakrishnan,et al.  Intermediary metabolism of mycobacteria. , 1972, Bacteriological reviews.

[36]  P. D. Hart,et al.  RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM TUBERCULOSIS, WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMES , 1971, The Journal of experimental medicine.

[37]  P. Bonventre,et al.  Uptake of 3H-Dihydrostreptomycin by Macrophages in Culture , 1970, Infection and immunity.

[38]  W. Mcdermott,et al.  Pyrazinamide susceptibility and amidase activity of tubercle bacilli. , 1967, The American review of respiratory disease.

[39]  N. Katunuma,et al.  The occurrence of ammonia-activiating enzyme in various organisms. , 1959, Archives of biochemistry and biophysics.

[40]  M. Sprick.  Phagocytosis of M. tuberculosis and M. smegmatis stained with indicator dyes. , 1956, American review of tuberculosis.

[41]  G. Mackaness.  The intracellular activation of pyrazinamide and nicotinamide. , 1956, American review of tuberculosis.

[42]  W. Mcdermott,et al.  Activation of pyrazinamide and nicotinamide in acidic environments in vitro. , 1954, American review of tuberculosis.

[43]  H. Eagle,et al.  The effect of the pH of the medium on the antibacterial action of penicillin, streptomycin, chloramphenicol, terramycin, and bacitracin. , 1952, Antibiotics & chemotherapy.

[44]  G. Mackaness.  The action of drugs on intracellular tubercle bacilli. , 1952, The Journal of pathology and bacteriology.

[45]  N. L. Edson.  THE INTERMEDIARY METABOLISM OF THE MYCOBACTERIA , 1951 .

[46]  M. H. Merrill.  CARBOHYDRATE METABOLISM OF ORGANISMS OF THE GENUS MYCOBACTERIUM , 1930, Journal of bacteriology.

[47]  P. Rous.  THE RELATIVE REACTION WITHIN LIVING MAMMALIAN-TISSUES , 1925, Journal of Experimental Medicine.